Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy

By Khatami Ali   Hugosson Jonas   Wang Wanzhong   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 12-18

Informa Healthcare

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

By Gunia Sven   Albrecht Knut   Koch Stefan   Herrmann Thomas   Ecke Thorsten   Loy Volker   Linke Jörg   Siegsmund Michael   May Matthias  

World Journal of Urology, Vol. 26, Iss. 3, 2008-06 ,pp. : 243-250

Springer Publishing Company

Access to resources Recommend Favorite

Probability of biochemical recurrence by analysis of pathologic stage, gleason score, and margin status for localized prostate cancer

By Khan M.A.   Partin A.W.   Mangold L.A.   Epstein J.I.   Walsh P.C.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 866-871

Elsevier

Access to resources Recommend Favorite

Should Gleason score 7 prostate cancer be considered a unique grade category? - the John Hopkins experience after 10 years

By Tefilli M.V.   Gheiler E.L.   Tiguert R.   Sakr W.   Grignon D.J.   Banerjee M.   Pontes J.E.   Wood D.P.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 372-377

Elsevier

Access to resources Recommend Favorite